-+ 0.00%
-+ 0.00%
-+ 0.00%

Maxim Group Downgrades Akari Therapeutics to Hold

Benzinga·04/08/2026 13:22:39
Listen to the news
Maxim Group analyst Jason McCarthy downgrades Akari Therapeutics (NASDAQ:AKTX) from Buy to Hold.